Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative Ketamine for Perioperative Depression
NCT04220125Phase 4Withdrawn
- Sponsor
- Northwestern University
- Start
- Sep 2022
- Primary completion
- Feb 2023
01
Overview
A Phase 4 trial of ketamine in major depressive disorder (MDD), sponsored by Northwestern University. Planned start Sep 2022; status: withdrawn.
02
Drugs
ketamine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT04220125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04220125.